HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹6.83 Cr | ₹8.51 Cr | ₹11 Cr | ₹26 Cr | ₹21 Cr |
What is the latest Net Current Assets ratio of HALEOS LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹6.83 Cr |
| Mar2025 | ₹8.51 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹21 Cr |
How is Net Current Assets of HALEOS LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.83 Cr | -19.73 | |
| Mar2025 | ₹8.51 Cr | -20.61 | |
| Mar2024 | ₹11 Cr | -58.07 | |
| Mar2023 | ₹26 Cr | 24.19 | |
| Mar2022 | ₹21 Cr | - | |
Compare Net Current Assets of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹414.0 Cr | -3.5% | -6.3% | 29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | -3.5% |
-6.3% |
29.5% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses